We also found that delphinidin reduces tumor growth of melanoma cells in vivo by acting specifically on endothelial cell proliferation via the inhibition of VEGFR2 signaling, MAPK, PI3K and at transcription level on CREB/ATF1 factors, and the inhibition of phosphodiesterase 2 [9]. This evidence concerns the gene ATF1 and neoplasm.